Patients with SSc exhibit elevated Th17 cell frequencies compared to healthy controls, as demonstrated by heightened expression of RORγt (the master transcriptional regulator of Th17 differentiation), increased IL-17A mRNA levels, and elevated proinflammatory cytokines (IL-1β, IL-6, and TNF-α). This evidence concerns the gene IL17A and systemic sclerosis.